Form 4: Molina Healthcare CLO Boosts Stake with Restricted Stock Grant

Molina Healthcare's Chief Legal Officer, Jeff D. Barlow, increased his beneficial ownership through a significant restricted stock grant, alongside a tax-related share disposition.

Summary

• Jeff D. Barlow, Chief Legal Officer of Molina Healthcare, Inc. (MOH), reported transactions on March 1, 2026.
• Disposed of 1,638 shares of common stock at a price of $154.05 per share to cover withholding taxes arising from the vesting of 4,183 shares.
• Acquired 13,722 shares of common stock as a restricted stock grant under the Issuer's 2025 Equity Incentive Plan at a volume-weighted average price of $145.75.
• Following these transactions, Barlow's direct beneficial ownership of common stock increased to 84,986 shares.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this filing as moderately positive, reflecting continued executive alignment through a significant restricted stock grant, which is a standard and healthy practice for incentivizing long-term performance.

Positives

• The grant of 13,722 restricted shares aligns the Chief Legal Officer's interests with long-term shareholder value.
• The new restricted shares will vest over three years, providing a sustained incentive for executive performance.

Negatives

• Disposition of 1,638 shares for tax withholding reduces direct ownership, though this is a standard practice for vested equity.

Risks

• No specific company-wide risks are detailed in this Form 4 filing.

Future Outlook

The 13,722 newly granted restricted shares are scheduled to vest in one-third increments on March 1, 2027, March 1, 2028, and March 1, 2029. Additionally, 2,722 shares will vest on March 1, 2027, and 1,619 shares on March 1, 2028.

Management Comments

• No direct management comments or notable quotes are provided in this Form 4 filing, which is a standard disclosure for insider transactions.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine regulatory disclosures detailing changes in beneficial ownership by company insiders. The grant of restricted stock and subsequent tax-related disposition are common components of executive compensation packages across the healthcare industry, designed to align management incentives with long-term shareholder value. This filing does not indicate any broader strategic shifts or competitive positioning.

Comparison to Industry Standards

• The compensation structure involving restricted stock grants with multi-year vesting schedules is a common practice for executive compensation in large publicly traded companies, including those in the healthcare sector like UnitedHealth Group (UNH) or Elevance Health (ELV).
• The disposition of shares to cover tax obligations upon vesting is also a standard and expected event, reflecting typical equity compensation mechanics rather than a unique company-specific event.

Related Party Transactions

• The grant of restricted stock and the disposition of shares for tax withholding are transactions between the company and its Chief Legal Officer, which are considered related party transactions in the context of executive compensation.

Stakeholder Impact

• Shareholders: The grant of restricted stock aligns the Chief Legal Officer's interests with long-term shareholder value.
• Management: The Chief Legal Officer's compensation package is enhanced, providing long-term incentives.

Next Steps

• Vesting of 4,574 shares (one-third of 13,722) on March 1, 2027.
• Vesting of 2,722 additional shares on March 1, 2027.
• Vesting of 4,574 shares (one-third of 13,722) on March 1, 2028.
• Vesting of 1,619 additional shares on March 1, 2028.
• Vesting of 4,574 shares (remaining one-third of 13,722) on March 1, 2029.

Key Dates

Recommendation

This Form 4 filing details routine executive compensation, including a substantial restricted stock grant, which is a positive for aligning management incentives with shareholder interests. However, it does not contain new financial performance data or strategic announcements that would warrant a change from a 'hold' position, as these are standard insider transactions.

Keywords

Molina Healthcare, MOH, Jeff D. Barlow, Chief Legal Officer, Form 4, insider transaction, restricted stock grant, equity incentive plan, stock ownership, executive compensation